Concepedia

Kelsey Schwensen

KS

Statistics

Publications

6

Citations

436

H-Index

6

Active since

2021

Affiliations

University of Kansas Medical Center(Current)

The University of Kansas Cancer Center

Kelsey Schwensen is an author at University of Kansas Medical Center specializing in oncology, medicine, and chemotherapy.

Publications per year

2021–2023

6

Publications

6

Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer

Priyanka Sharma, Shane R. Stecklein, Rachel Yoder et al. · JAMA Oncology · 2023 · 164 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer

Priyanka Sharma, Vandana G. Abramson, Anne O’Dea et al. · Clinical Cancer Research · 2021 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

Rachel Yoder, Bruce F. Kimler, Joshua M. Staley et al. · npj Breast Cancer · 2022 · 74 citations · Full text

Medicine, Oncology, Breast Oncology +13

Clinical and biomarker results of neoadjuvant phase II study of pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer (TNBC) (NeoPACT).

Priyanka Sharma, Shane R. Stecklein, Rachel Yoder et al. · Journal of Clinical Oncology · 2022 · 51 citations

Pharmacy, Pharmacology, Cancer Drug Toxicity Management +13

ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease

Shane R. Stecklein, Bruce F. Kimler, Rachel Yoder et al. · npj Breast Cancer · 2023 · 42 citations · Full text

Medicine, Oncology, Breast Oncology +15

1–5 of 6